First Header Logo Second Header Logo

Thomas Wierzba

Concepts (288)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholera Vaccines
19
2019
19
5.350
Why?
Typhoid Fever
17
2019
19
5.070
Why?
Cholera
21
2019
21
4.780
Why?
Diarrhea
19
2019
56
4.240
Why?
Escherichia coli Infections
14
2019
37
3.660
Why?
Escherichia coli Vaccines
8
2019
10
2.800
Why?
Dysentery, Bacillary
8
2019
12
2.400
Why?
Enterotoxigenic Escherichia coli
8
2019
15
2.130
Why?
Shigella Vaccines
5
2019
5
2.050
Why?
Child, Preschool
45
2019
1095
2.020
Why?
Vaccination
10
2016
100
1.930
Why?
Infant
41
2019
895
1.930
Why?
Child
45
2019
2007
1.890
Why?
Hepatitis E
4
2018
6
1.840
Why?
Salmonella Infections
9
2018
11
1.810
Why?
Developing Countries
8
2019
38
1.680
Why?
Adolescent
42
2019
3127
1.610
Why?
Disease Outbreaks
7
2018
35
1.600
Why?
Antibodies, Bacterial
6
2019
31
1.470
Why?
Mass Vaccination
5
2016
7
1.430
Why?
Influenza, Human
7
2014
120
1.310
Why?
Humans
88
2019
28451
1.290
Why?
Models, Theoretical
3
2018
133
1.190
Why?
Typhoid-Paratyphoid Vaccines
5
2019
6
1.190
Why?
Shigella
5
2019
7
1.110
Why?
Immunity, Herd
4
2019
5
1.110
Why?
Fever
7
2018
55
1.050
Why?
Young Adult
28
2019
2372
1.020
Why?
India
13
2018
62
1.000
Why?
Administration, Oral
14
2019
174
0.990
Why?
Population Surveillance
8
2014
122
0.930
Why?
Bacterial Vaccines
2
2012
7
0.900
Why?
Paratyphoid Fever
2
2019
3
0.870
Why?
Female
49
2019
18228
0.870
Why?
Salmonella
3
2018
3
0.850
Why?
Vibrio cholerae
3
2015
3
0.850
Why?
Adult
34
2019
8519
0.840
Why?
Escherichia coli
5
2014
79
0.790
Why?
Viral Vaccines
2
2011
13
0.790
Why?
Salmonella typhi
9
2018
10
0.790
Why?
Male
46
2019
17995
0.770
Why?
Incidence
12
2018
1072
0.760
Why?
Vaccines, Conjugate
4
2019
14
0.720
Why?
Sanitation
1
2018
5
0.720
Why?
Hygiene
1
2018
17
0.710
Why?
Rotavirus Infections
4
2019
10
0.710
Why?
Mortality
2
2019
108
0.660
Why?
Enteritis
2
2019
5
0.630
Why?
Encephalitis, Japanese
3
2015
3
0.620
Why?
Immunization, Secondary
2
2016
9
0.610
Why?
Severity of Illness Index
3
2016
883
0.610
Why?
Rural Population
8
2016
290
0.590
Why?
Vaccines, Inactivated
9
2018
36
0.580
Why?
Environmental Monitoring
2
2013
30
0.580
Why?
Reagent Kits, Diagnostic
2
2012
8
0.570
Why?
Water Supply
1
2014
12
0.550
Why?
Enteropathogenic Escherichia coli
1
2014
3
0.550
Why?
Influenza A Virus, H1N1 Subtype
2
2012
48
0.550
Why?
Diarrhea, Infantile
1
2014
6
0.550
Why?
Intestinal Perforation
1
2014
9
0.530
Why?
Anti-Bacterial Agents
8
2016
277
0.510
Why?
Salmonella enterica
4
2016
5
0.500
Why?
Cause of Death
1
2014
222
0.490
Why?
Length of Stay
1
2014
290
0.470
Why?
Egypt
12
2014
16
0.470
Why?
Neisseria meningitidis, Serogroup A
1
2012
1
0.460
Why?
Residence Characteristics
2
2016
161
0.450
Why?
Clinical Trials as Topic
5
2019
312
0.450
Why?
Point-of-Care Systems
1
2012
30
0.440
Why?
Africa South of the Sahara
8
2018
12
0.440
Why?
Infant, Newborn
14
2019
560
0.420
Why?
Feces
6
2019
28
0.410
Why?
Cambodia
8
2014
8
0.400
Why?
Bacteremia
3
2016
50
0.400
Why?
Double-Blind Method
7
2018
519
0.400
Why?
Bacterial Infections
2
2012
40
0.400
Why?
Enzyme-Linked Immunosorbent Assay
5
2018
158
0.390
Why?
Campylobacter Infections
2
2008
6
0.380
Why?
Measles
1
2009
2
0.380
Why?
Immunization
2
2019
27
0.380
Why?
Guillain-Barre Syndrome
1
2008
7
0.370
Why?
Tanzania
9
2015
10
0.360
Why?
Congresses as Topic
2
2019
41
0.360
Why?
Malaria
4
2016
9
0.330
Why?
Urban Population
3
2017
77
0.330
Why?
Ciprofloxacin
3
2016
12
0.320
Why?
Cost of Illness
3
2018
60
0.320
Why?
Prevalence
6
2016
901
0.310
Why?
Family Characteristics
2
2017
35
0.300
Why?
Middle Aged
12
2018
11102
0.300
Why?
Risk Factors
5
2018
3527
0.280
Why?
Cohort Studies
8
2019
1662
0.280
Why?
Databases, Factual
2
2016
328
0.270
Why?
Japanese Encephalitis Vaccines
2
2015
2
0.270
Why?
Antibodies, Viral
2
2016
52
0.270
Why?
Socioeconomic Factors
2
2017
401
0.260
Why?
Bangladesh
6
2019
7
0.250
Why?
Drug Resistance, Bacterial
3
2016
35
0.250
Why?
Drug Resistance, Multiple, Bacterial
2
2016
14
0.250
Why?
Patient Acceptance of Health Care
2
2016
155
0.240
Why?
Immunization Schedule
3
2019
21
0.220
Why?
Nepal
3
2014
9
0.220
Why?
Escherichia coli Proteins
3
2005
26
0.200
Why?
Case-Control Studies
5
2015
917
0.200
Why?
Rotavirus Vaccines
1
2019
6
0.190
Why?
Antigens, Bacterial
1
2019
18
0.190
Why?
Geographic Information Systems
1
2019
15
0.190
Why?
Cross-Sectional Studies
5
2016
1325
0.190
Why?
Sensitivity and Specificity
5
2012
523
0.190
Why?
Host-Pathogen Interactions
1
2019
30
0.190
Why?
Growth Disorders
1
2019
3
0.190
Why?
Cost-Benefit Analysis
1
2019
144
0.180
Why?
Pregnant Women
1
2018
5
0.180
Why?
Hepatitis Antibodies
1
2018
1
0.180
Why?
Jaundice
1
2018
4
0.180
Why?
Treatment Outcome
7
2015
3025
0.170
Why?
Macaca mulatta
1
2019
322
0.170
Why?
Gastrointestinal Diseases
1
2018
42
0.170
Why?
Disease Models, Animal
2
2019
1021
0.170
Why?
Seroepidemiologic Studies
2
2014
8
0.170
Why?
Africa
2
2014
24
0.170
Why?
Pregnancy
3
2017
743
0.170
Why?
Hepatitis E virus
2
2014
3
0.160
Why?
Vietnam
2
2014
4
0.160
Why?
Drug Resistance, Multiple
1
2017
7
0.160
Why?
Pregnancy Complications, Infectious
2
2014
25
0.160
Why?
Microbial Sensitivity Tests
6
2016
49
0.160
Why?
Washington
1
2016
3
0.160
Why?
Milk, Human
1
2017
16
0.160
Why?
Fatty Acids, Omega-6
1
2017
31
0.160
Why?
Geography
2
2014
32
0.160
Why?
Education
1
2016
33
0.160
Why?
Aged, 80 and over
5
2016
3691
0.160
Why?
Influenza A Virus, H9N2 Subtype
2
2014
3
0.160
Why?
Fatty Acids, Omega-3
1
2017
49
0.160
Why?
Endemic Diseases
1
2016
4
0.150
Why?
World Health Organization
2
2014
15
0.150
Why?
Indonesia
1
2016
1
0.150
Why?
Nigeria
1
2016
1
0.150
Why?
Uganda
1
2016
5
0.150
Why?
Enterotoxins
3
2005
6
0.150
Why?
Bacterial Toxins
3
2005
17
0.150
Why?
Immunity, Mucosal
1
2016
5
0.150
Why?
Poliovirus
1
2016
3
0.150
Why?
Antibody-Producing Cells
1
2016
3
0.150
Why?
Database Management Systems
1
2016
11
0.150
Why?
Public Health
2
2014
68
0.150
Why?
Hospitalization
2
2016
395
0.150
Why?
Immunoglobulin A
4
2019
8
0.150
Why?
Salmonella paratyphi A
2
2013
2
0.150
Why?
Aged
6
2016
9561
0.140
Why?
B-Lymphocytes
1
2016
69
0.140
Why?
Research Design
2
2015
277
0.140
Why?
Haemophilus Vaccines
1
2015
1
0.140
Why?
Bacterial Capsules
1
2015
4
0.140
Why?
Haemophilus Infections
1
2015
5
0.140
Why?
Immunoglobulin G
4
2019
103
0.140
Why?
Mice
2
2019
2372
0.140
Why?
Longitudinal Studies
2
2016
722
0.140
Why?
Health Expenditures
1
2015
57
0.140
Why?
Bacteriological Techniques
1
2014
14
0.140
Why?
Genotype
2
2014
825
0.140
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2011
247
0.130
Why?
Phenotype
2
2014
662
0.130
Why?
Bayes Theorem
1
2014
64
0.130
Why?
Salmonella Vaccines
1
2013
1
0.130
Why?
Internationality
1
2013
20
0.130
Why?
Animals
5
2019
7456
0.130
Why?
Population Density
1
2013
6
0.130
Why?
Educational Status
1
2014
161
0.120
Why?
Randomized Controlled Trials as Topic
1
2015
451
0.120
Why?
Republic of Korea
1
2012
8
0.120
Why?
Models, Statistical
1
2013
158
0.120
Why?
Computers, Handheld
1
2012
7
0.120
Why?
Niger
1
2012
1
0.120
Why?
Dengue
1
2012
4
0.120
Why?
Delivery of Health Care
1
2014
126
0.110
Why?
Community-Acquired Infections
1
2012
32
0.110
Why?
Influenza A Virus, H3N2 Subtype
1
2011
22
0.110
Why?
Reproducibility of Results
4
2016
705
0.110
Why?
Sex Factors
1
2014
650
0.110
Why?
Data Collection
1
2012
167
0.110
Why?
Vibrio cholerae O1
3
2015
3
0.110
Why?
Rotavirus
1
2010
3
0.100
Why?
Orthomyxoviridae
1
2010
14
0.100
Why?
Health Services Accessibility
1
2012
221
0.100
Why?
Health Knowledge, Attitudes, Practice
1
2014
326
0.100
Why?
Fluoroquinolones
1
2009
10
0.100
Why?
Asia
3
2013
16
0.090
Why?
Gangliosides
1
2008
6
0.090
Why?
Indian Ocean Islands
3
2013
3
0.090
Why?
Cluster Analysis
3
2013
123
0.090
Why?
Prospective Studies
4
2017
1951
0.090
Why?
Retrospective Studies
3
2014
2921
0.080
Why?
Azithromycin
2
2004
13
0.080
Why?
Hospitals
3
2012
72
0.080
Why?
Survival Rate
1
2009
813
0.080
Why?
Vaccines, Subunit
2
2016
3
0.080
Why?
Ghana
2
2016
22
0.080
Why?
Seasons
1
2006
95
0.070
Why?
Cryptosporidiosis
1
2005
2
0.070
Why?
Cryptosporidium parvum
1
2005
2
0.070
Why?
Tuberculosis, Meningeal
1
2005
1
0.070
Why?
Tuberculoma, Intracranial
1
2005
1
0.070
Why?
Granuloma
1
2005
13
0.070
Why?
Interferon-gamma
1
2005
51
0.070
Why?
Interleukin-10
1
2005
30
0.070
Why?
Placebos
2
2015
66
0.070
Why?
Biomedical Research
2
2016
158
0.070
Why?
Campylobacter coli
1
2003
2
0.070
Why?
Campylobacter jejuni
1
2003
3
0.070
Why?
Probability
3
2012
148
0.060
Why?
Cholera Toxin
1
2002
5
0.060
Why?
Age Factors
2
2016
1123
0.060
Why?
Proportional Hazards Models
2
2015
717
0.060
Why?
Serotyping
2
2016
14
0.060
Why?
Adjuvants, Immunologic
1
2002
52
0.060
Why?
Bacteria
2
2012
44
0.060
Why?
Prognosis
3
2016
1374
0.050
Why?
Shigella sonnei
1
2019
1
0.050
Why?
Vaccines, Attenuated
1
2019
11
0.050
Why?
Dose-Response Relationship, Immunologic
1
2019
14
0.050
Why?
Quality-Adjusted Life Years
1
2019
23
0.050
Why?
Luminescent Measurements
1
2018
17
0.050
Why?
Electrochemical Techniques
1
2018
22
0.050
Why?
Age Distribution
2
2012
197
0.040
Why?
Vaccines, Combined
1
2017
4
0.040
Why?
Lactation
1
2017
14
0.040
Why?
Guinea-Bissau
1
2016
1
0.040
Why?
Senegal
1
2016
1
0.040
Why?
Molecular Epidemiology
1
2016
21
0.040
Why?
Clinical Audit
1
2016
1
0.040
Why?
Poliomyelitis
1
2016
2
0.040
Why?
Poliovirus Vaccine, Oral
1
2016
3
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2016
2
0.040
Why?
Antibodies, Neutralizing
1
2016
17
0.040
Why?
Weights and Measures
1
2015
3
0.040
Why?
Anthropometry
1
2016
83
0.040
Why?
Ethiopia
1
2015
1
0.040
Why?
Vibrio cholerae O139
1
2015
1
0.040
Why?
Outpatients
1
2015
54
0.040
Why?
Democratic People's Republic of Korea
1
2015
1
0.040
Why?
Inpatients
1
2015
52
0.040
Why?
Fimbriae Proteins
2
2005
5
0.030
Why?
Analysis of Variance
1
2016
472
0.030
Why?
Influenza A Virus, H5N1 Subtype
1
2014
3
0.030
Why?
Vulnerable Populations
1
2014
24
0.030
Why?
History, 21st Century
1
2014
47
0.030
Why?
History, 20th Century
1
2014
66
0.030
Why?
Drug Discovery
1
2013
32
0.030
Why?
Body Mass Index
1
2017
874
0.030
Why?
Poverty Areas
1
2013
4
0.030
Why?
Agglutination Tests
1
2012
2
0.030
Why?
Technology, Pharmaceutical
1
2012
3
0.030
Why?
Immunization Programs
1
2012
16
0.030
Why?
Communication
1
2014
116
0.030
Why?
Health Policy
1
2012
72
0.030
Why?
Hantavirus
1
2012
1
0.030
Why?
Orientia tsutsugamushi
1
2012
1
0.030
Why?
Rickettsia
1
2012
3
0.030
Why?
Medical Records Systems, Computerized
1
2012
21
0.030
Why?
Pilot Projects
1
2014
462
0.030
Why?
Specimen Handling
1
2012
25
0.030
Why?
Information Storage and Retrieval
1
2012
26
0.030
Why?
Risk
1
2013
298
0.030
Why?
Decision Making
1
2014
173
0.030
Why?
Models, Biological
1
2013
369
0.030
Why?
Feasibility Studies
1
2012
251
0.030
Why?
Acute Disease
1
2012
244
0.030
Why?
Pharyngitis
1
2010
12
0.030
Why?
Cough
1
2010
19
0.030
Why?
RNA, Viral
1
2010
54
0.030
Why?
Time Factors
1
2015
2000
0.020
Why?
Occupational Exposure
1
2013
285
0.020
Why?
Predictive Value of Tests
1
2010
778
0.020
Why?
Virulence Factors
1
2005
7
0.020
Why?
Brain
1
2012
955
0.020
Why?
Virulence
1
2004
19
0.020
Why?
Sex Distribution
1
2005
184
0.020
Why?
Bacterial Proteins
1
2005
70
0.020
Why?
Erythromycin
1
2003
5
0.020
Why?
Multivariate Analysis
1
2005
661
0.020
Why?
Logistic Models
1
2005
745
0.010
Why?
Evidence-Based Medicine
1
2004
202
0.010
Why?
Pediatrics
1
2003
123
0.010
Why?
Antibody Formation
1
2002
37
0.010
Why?
Dose-Response Relationship, Drug
1
2002
656
0.010
Why?
Risk Assessment
1
2005
1299
0.010
Why?
Wierzba's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (288)
Explore
_
Co-Authors (1)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_